Holen Sie sich die Stockscreener-App
28.29
2.41%
-0.70
Handel nachbörslich:
28.29
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
92,904 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Raymond James Financial Inc. - MarketBeat
Quantbot Technologies LP Invests $945,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
(AMPH) Investment Report - news.stocktradersdaily.com
Fox Run Management L.L.C. Takes $688,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award - ACCESS Newswire
Amphastar Wins FDA Award: How Its Solution to Critical Drug Shortage Signals Major Growth - Stock Titan
Intech Investment Management LLC Increases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - MarketBeat
Boston Partners Purchases Shares of 426,636 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Hypoglycemia Pipeline 2025: FDA Approvals, Therapies, - openPR.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by PNC Financial Services Group Inc. - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Amundi - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Piper Sandler Lowers Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $32.00 - Defense World
Charles Schwab Investment Management Inc. Sells 2,544 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar stock target cut to $32 by Piper Sandler, maintains neutral - Investing.com Canada
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amundi Acquires 12,899 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals Inc (AMPH) Shares Up 0.46% on Mar 19 - GuruFocus
US Bancorp DE Has $31,000 Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
(AMPH) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
On Nasdaq, I Prefer The Less-Famous Stocks - Forbes
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 52-Week LowTime to Sell? - MarketBeat
Wealthfront Advisers LLC Acquires New Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Smartleaf Asset Management LLC Increases Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks - Yahoo Finance
Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks | FinancialContent - Financial Content
Amphastar stock hits 52-week low at $26.97 amid market challenges - Investing.com Australia
Amphastar at Barclays Conference: Strategic Focus on Growth and Innovation By Investing.com - Investing.com UK
Amphastar stock hits 52-week low at $26.97 amid market challenges By Investing.com - Investing.com South Africa
Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) CFO Sells 4,231 Shares of Stock - MarketBeat
Amphastar Pharmaceuticals Inc to Host Earnings Call - ACCESS Newswire
(AMPH) Proactive Strategies - news.stocktradersdaily.com
Amphastar Pharmaceuticals director Petersen sells $27,986 in stock By Investing.com - Investing.com South Africa
Amphastar Pharmaceuticals director Petersen sells $27,986 in stock - Investing.com India
Amphastar Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire
Amphastar Pharmaceuticals CFO sells $116,515 in stock By Investing.com - Investing.com Australia
1.48%
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):